OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity
Yi-Fei Xuan, Shan Lu, Ying-Jie Ou, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 716, pp. 150011-150011
Closed Access | Times Cited: 8
Yi-Fei Xuan, Shan Lu, Ying-Jie Ou, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 716, pp. 150011-150011
Closed Access | Times Cited: 8
Showing 8 citing articles:
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 28
Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications
Yuqiang Liu, Yu Zhao, Huisheng Song, et al.
Cancer Letters (2024) Vol. 597, pp. 217076-217076
Open Access | Times Cited: 20
Yuqiang Liu, Yu Zhao, Huisheng Song, et al.
Cancer Letters (2024) Vol. 597, pp. 217076-217076
Open Access | Times Cited: 20
S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy
David Fernández‐Ramos, Fernando Lopitz‐Otsoa, Shelly C. Lu, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 535-535
Open Access | Times Cited: 1
David Fernández‐Ramos, Fernando Lopitz‐Otsoa, Shelly C. Lu, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 535-535
Open Access | Times Cited: 1
Patent landscape of small molecule inhibitors of METTL3 (2020-present)
Zhixing Wu, Alexis R. Smith, Zhijian Qian, et al.
Expert Opinion on Therapeutic Patents (2024), pp. 1-16
Closed Access | Times Cited: 4
Zhixing Wu, Alexis R. Smith, Zhijian Qian, et al.
Expert Opinion on Therapeutic Patents (2024), pp. 1-16
Closed Access | Times Cited: 4
The combination of BET and METTL3 inhibitors elicits synergistic antitumor effects in ovarian cancer cells via reducing SP1 and BCL-2 expression
Ying-Jie Ou, B. N. Liu, Yi-Fei Xuan, et al.
Life Sciences (2025), pp. 123505-123505
Closed Access
Ying-Jie Ou, B. N. Liu, Yi-Fei Xuan, et al.
Life Sciences (2025), pp. 123505-123505
Closed Access
System metabolic engineering modification of Saccharomyces cerevisiae to increase SAM production
Liangzhuang Tan, Yuehan Zhang, Ping Liu, et al.
Bioresources and Bioprocessing (2025) Vol. 12, Iss. 1
Open Access
Liangzhuang Tan, Yuehan Zhang, Ping Liu, et al.
Bioresources and Bioprocessing (2025) Vol. 12, Iss. 1
Open Access
Role of N6‐methyladenosine RNA modification in cancer
Yi Qu, Nannan Gao, Shengwei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 3
Yi Qu, Nannan Gao, Shengwei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 3
MTAP as an emerging biomarker in thoracic malignancies
Magdalena M. Brune, Spasenija Savic Prince, Tatjana Vlajnic, et al.
Lung Cancer (2024) Vol. 197, pp. 107963-107963
Open Access | Times Cited: 1
Magdalena M. Brune, Spasenija Savic Prince, Tatjana Vlajnic, et al.
Lung Cancer (2024) Vol. 197, pp. 107963-107963
Open Access | Times Cited: 1
